{
    "medicine_id": "c0e2e6244154f5474002ca42a2b3db43204245ee",
    "platform_id": "DB00020",
    "metadata": {
        "name": "Leukine 500 ug 1mL Liquid",
        "composition": "500 ug 1mL Sargramostim",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of cancer and bone marrow transplant",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Sargramostim is used in the treatment of bone marrow transplant recipients or those exposed to chemotherapy an recovering from acut myelogenous leukemia Leukine or GM CSF is a hematopoietic growth factor which stimulates the survival clonal expansion proliferation and differentiation of hematopoietic progenitor cells GM CSF is also capable of activating mature granulocytes and macrophages After a bone marrow transplant or chemotherapy patients have a reduced capacity to produce red and white blood cells Supplementing them with external sources of GM CSF helps bring the level of neutrophils back to normal so that they can better fight infections",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of adverse effects can be increased when Sargramostim is combined with Bleomycin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Sargramostim"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB05168",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vintafolide"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinflunine"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincamine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}